News
Public · Published
BrightSpring Health Services 3Q 2026: Revenue $4.21B, Net income $100.1M, EPS $0.45— 10-Q Summary
BrightSpring Health Services reported third-quarter 2026 revenue of $4.21B, up 26.4% from $3.33B a year earlier. Net income rose to $100.1M from $55.8M, and diluted earnings per share, which means profit per share, increased to $0.45 from $0.26.
Published:
Updated:
What happened
BrightSpring Health Services reported third-quarter 2026 revenue of $4.21B, up 26.4% from $3.33B a year earlier. Net income rose to $100.1M from $55.8M, and diluted earnings per share, which means profit per share, increased to $0.45 from $0.26.
Confirmed
Global impact / market context
Profit grew faster than revenue because net income rose 79.4% while revenue rose 26.4%, so more of each sales dollar reached the bottom line. Acquisitions of Amedisys and LHC branches added $76.1M of revenue, showing bought growth supplemented organic volume and rate gains.
Analyst inference
Pharmacy Solutions revenue rose 25.8%, led by 33.8% growth in Specialty and Infusion Pharmacy on higher specialty branded drug prescription volume, while Home and Community Pharmacy fell 6.3%. Provider Services grew 31.0%. This mix shift means investors can weigh which segments drive profit, not just total revenue.
Analyst inference
What to watch
- Home and Community Pharmacy revenue declined 6.3% while total revenue rose 26.4%, so watch whether this segment keeps shrinking and whether other segments must carry overall growth. Confirmed
- The company plans selective expansion and greater integration of care, including value-based care, which means paying for outcomes rather than volume, so watch for details on timing and cost. Proposed
- Acquisitions of Amedisys and LHC branches added $76.1M to quarterly revenue, so watch whether purchased revenue converts into lasting profit and whether integration costs affect future results. Analyst inference
Evidence
- Original source link unavailable